We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Research Subjects May Waive Rights to Biospecimens, FDA, OHRP Say
Research Subjects May Waive Rights to Biospecimens, FDA, OHRP Say
September 8, 2011
Sponsors may be able to state in informed consent documents that subjects are giving up legal rights to compensation for their biospecimens now that a draft guidance states this language is not exculpatory.